Playlist
Capital-Based Logistics Enterprise Announces Openings for Heavy-Duty Truck Drivers
22 Jun. 10:42A major public sector transport and logistics organization has opened recruitment for qualified professionals experienced in operating heavy cargo vehicles. The enterprise is specifically expanding its team of operators for high-capacity "KamAZ 6520" trucks to support growing freight operations.
Key Requirements and Terms:
Licensing: Candidates must hold a valid driver's license with a confirmed "C" category classification.
Open Geography: There are no regional residency or registration restrictions. Qualified applicants from all provinces across the country are equally welcome to apply.
This recruitment drive is a direct response to the continuous expansion of regional transport networks, increasing shipping volumes, and new infrastructure developments. The employer provides stable employment terms alongside modern working standards.
For inquiries, operational details, and application procedures, candidates can reach out directly via the following contact lines: +993 12 76-06-19 or +993 12 76-02-56.
Also read
American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.
Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.
Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.
Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.
Blitz